Skip to content

Clinical trials

Diabetic Nephropathies trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: Japan Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20052
20061
20081
20111
20121
20132
20143
20154
20162
20182
20192
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation5
AstraZeneca4
Bayer3
Daiichi Sankyo Co., Ltd.3
Boehringer Ingelheim2
Kyowa Kirin Co., Ltd.2
AbbVie (prior sponsor, Abbott)1
Daiichi Sankyo1
Dokkyo Medical University1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies30
Diabetes Mellitus, Type 212
Renal Insufficiency, Chronic7
Diabetes Mellitus5
Kidney Diseases5
Hypertension3
Proteinuria3
Renal Insufficiency3
Kidney Failure, Chronic2
Albuminuria1

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.